{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:22:01Z","timestamp":1787952121341,"version":"build-2784847793"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.blre.2026.101417","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:46:45Z","timestamp":1782888405000},"page":"101417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["What population-based databases reveal about equity in access to hematopoietic cell transplant and cellular therapy"],"prefix":"10.1016","volume":"77","author":[{"given":"Sanghee","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Ricardo","family":"Espinoza-Gutarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Demartino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella M.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eneida","family":"Nemecek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianna","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"DeSalvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa L.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navneet S.","family":"Majhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Preussler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurekha G.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra Gomez","family":"Arteaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery J.","family":"Auletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandita","family":"Khera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2026.101417_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101136","article-title":"Access to CAR T-cell therapy: focus on diversity, equity and inclusion","volume":"63","author":"Odstrcil","year":"2024","journal-title":"Blood Rev"},{"issue":"1","key":"10.1016\/j.blre.2026.101417_bb0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/hematology.2021000259","article-title":"Increasing access to allotransplants in the United States: the impact of race, geography, and socioeconomics","volume":"2021","author":"Hong","year":"2021","journal-title":"Hematology"},{"issue":"11","key":"10.1016\/j.blre.2026.101417_bb0015","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1080\/10428194.2025.2513003","article-title":"Access barriers to hematopoietic stem cell transplantation and CAR T-cells in US","volume":"66","author":"Odstrcil Bobillo","year":"2025","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"10.1016\/j.blre.2026.101417_bb0020","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1158\/0008-5472.CAN-22-1274","article-title":"Challenges to using big data in cancer","volume":"83","author":"Sweeney","year":"2023","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.blre.2026.101417_bb0025","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/jnci\/djab105","article-title":"Association of Medicaid Expansion with Cancer Stage and Disparities in newly diagnosed young adults","volume":"113","author":"Ji","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"10.1016\/j.blre.2026.101417_bb0030","doi-asserted-by":"crossref","first-page":"19960","DOI":"10.1002\/cam4.6537","article-title":"Decreasing incidence of hepatocellular carcinoma among most racial groups: SEER-22, 2000-2019","volume":"12","author":"O\u2019Brien","year":"2023","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.blre.2026.101417_bb0035","article-title":"Assessment of proton beam therapy use among patients with newly diagnosed cancer in the US, 2004\u20132018","volume":"5","author":"Nogueira","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.blre.2026.101417_bb0040","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jtct.2022.09.020","article-title":"The ASTCT-NMDP ACCESS initiative: a collaboration to address and sustain equal outcomes for all across the hematopoietic cell transplantation and cellular therapy ecosystem","volume":"28","author":"Auletta","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"12","key":"10.1016\/j.blre.2026.101417_bb0045","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jtct.2023.09.026","article-title":"Proceedings of the 2023 second annual ASTCT-NMDP ACCESS initiative workshop","volume":"29","author":"Auletta","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.blre.2026.101417_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2023.08.007","article-title":"Assessing Medicaid coverage for hematopoietic cell transplantation and chimeric antigen receptor T cell therapy: a project from the American Society for Transplantation and Cellular Therapy and the National Marrow Donor Program ACCESS initiative","author":"Auletta","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"12","key":"10.1016\/j.blre.2026.101417_bb0055","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jtct.2024.09.004","article-title":"Proceedings of the 2024 third annual ASTCT-NMDP ACCESS initiative workshop","volume":"30","author":"Auletta","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.blre.2026.101417_bb0060","author":"PRISMA"},{"key":"10.1016\/j.blre.2026.101417_bb0070","author":"CMS.gov"},{"issue":"12","key":"10.1016\/j.blre.2026.101417_bb0075","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jtct.2022.09.015","article-title":"Trends in allogeneic hematopoietic cell transplantation utilization and estimated unmet need among Medicare beneficiaries with acute myelogenous leukemia","volume":"28","author":"Mau","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"10.1016\/j.blre.2026.101417_bb0080","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jtct.2024.04.017","article-title":"Chimeric antigen receptor T-cell access in patients with relapsed\/refractory large B-cell lymphoma: association of access with social determinants of health and travel time to treatment centers","volume":"30","author":"Ahmed","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"12","key":"10.1016\/j.blre.2026.101417_bb0085","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1182\/blood.2023020197","article-title":"Real-world experience of CAR T-cell therapy in older patients with relapsed\/refractory diffuse large B-cell lymphoma","volume":"142","author":"Chihara","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101417_bb0090","first-page":"1","article-title":"Treatment patterns, healthcare resource utilization, and costs in Medicare patients with diffuse large B-cell lymphoma: a retrospective claims analysis (2015-2020)","author":"Jun","year":"2024","journal-title":"J Med Econ"},{"key":"10.1016\/j.blre.2026.101417_bb0095","author":"NCI"},{"key":"10.1016\/j.blre.2026.101417_bb0100","author":"Sciences NCIDoCCP"},{"issue":"4","key":"10.1016\/j.blre.2026.101417_bb0105","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.bbmt.2014.12.024","article-title":"Disparities in utilization of autologous hematopoietic cell transplantation for treatment of multiple myeloma","volume":"21","author":"Costa","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.blre.2026.101417_bb0110","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1038\/s41375-020-0830-0","article-title":"Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era","volume":"34","author":"Dhakal","year":"2020","journal-title":"Leukemia"},{"issue":"14","key":"10.1016\/j.blre.2026.101417_bb0115","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1002\/cncr.25297","article-title":"Access to hematopoietic stem cell transplantation: effect of race and sex","volume":"116","author":"Joshua","year":"2010","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.blre.2026.101417_bb0120","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.bbmt.2019.06.012","article-title":"Inferior access to allogeneic transplant in disadvantaged populations: a Center for International Blood and Marrow Transplant Research Analysis","volume":"25","author":"Paulson","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"16","key":"10.1016\/j.blre.2026.101417_bb0125","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1002\/cncr.30747","article-title":"Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: a CIBMTR report","volume":"123","author":"Schriber","year":"2017","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.blre.2026.101417_bb0130","doi-asserted-by":"crossref","first-page":"911.e1","DOI":"10.1016\/j.jtct.2021.08.014","article-title":"Outcomes and utilization trends of front-line autologous hematopoietic cell transplantation for mantle cell lymphoma","volume":"27","author":"Riedell","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"16","key":"10.1016\/j.blre.2026.101417_bb0135","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1200\/JCO.2012.46.3323","article-title":"Multiple myeloma treatment transformed: a population-based study of changes in initial management approaches in the United States","volume":"31","author":"Warren","year":"2013","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.blre.2026.101417_bb0140","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jtct.2024.10.014","article-title":"Representativeness of blood and marrow transplant clinical trials network (BMT CTN) trial participants","volume":"31","author":"Kaur","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"9","key":"10.1016\/j.blre.2026.101417_bb0145","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.33145","article-title":"Use of hematopoietic cell transplant for hematologic cancers by race, ethnicity, and age","volume":"7","author":"Hahn","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.blre.2026.101417_bb0150","series-title":"SEER_Medicare Linked Data Resource","author":"National-Cancer-Institute","year":"2025"},{"issue":"20","key":"10.1016\/j.blre.2026.101417_bb0155","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1182\/bloodadvances.2019000308","article-title":"Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis","volume":"3","author":"Ailawadhi","year":"2019","journal-title":"Blood Adv"},{"issue":"20","key":"10.1016\/j.blre.2026.101417_bb0160","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.1002\/cam4.4249","article-title":"Racial and ethnic differences in the utilization of autologous transplantation for lymphoma in the United States","volume":"10","author":"Vaughn","year":"2021","journal-title":"Cancer Med"},{"issue":"13","key":"10.1016\/j.blre.2026.101417_bb0165","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1080\/10428194.2019.1623886","article-title":"Temporal trends in treatment and survival of older adult diffuse large B-Cell lymphoma patients in the SEER-Medicare linked database","volume":"60","author":"Shaw","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.blre.2026.101417_bb0175","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/10428194.2021.1978085","article-title":"The impact of socioeconomic disparities on the use of upfront autologous stem cell transplantation for mantle cell lymphoma","volume":"63","author":"Sawalha","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"10.1016\/j.blre.2026.101417_bb0180","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ajh.23753","article-title":"Use of autologous hematopoietic cell transplantation as initial therapy in multiple myeloma and the impact of socio-geo-demographic factors in the era of novel agents","volume":"89","author":"Al-Hamadani","year":"2014","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.blre.2026.101417_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-024-01067-x","article-title":"Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparities","volume":"14","author":"Ailawadhi","year":"2024","journal-title":"Blood Cancer J"},{"issue":"6","key":"10.1016\/j.blre.2026.101417_bb0190","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s00277-023-05194-6","article-title":"Hospital facility characteristics and socioeconomic factors on outcomes and treatment in patients with multiple myeloma: National Cancer Database analysis","volume":"102","author":"Doucette","year":"2023","journal-title":"Ann Hematol"},{"issue":"13","key":"10.1016\/j.blre.2026.101417_bb0195","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2217\/fon-2017-0599","article-title":"Factors associated with receipt of hematopoietic cell transplantation for acute lymphoblastic leukemia","volume":"14","author":"Manikkam Umakanthan","year":"2018","journal-title":"Conference Paper Future Oncol"},{"key":"10.1016\/j.blre.2026.101417_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2024.06.021","article-title":"Current trends and outcomes in cellular therapy activity in the United States, including prospective patient-reported outcomes data collection in the Center for International Blood and Marrow Transplant Research Registry","author":"Cusatis","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"10.1016\/j.blre.2026.101417_bb0210","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/j.clml.2023.12.009","article-title":"Utilization of autologous hematopoietic cell transplantation over time in multiple myeloma: a population-based study","volume":"24","author":"Esteghamat","year":"2024","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"10","key":"10.1016\/j.blre.2026.101417_bb0215","doi-asserted-by":"crossref","first-page":"869.e1","DOI":"10.1016\/j.jtct.2021.06.030","article-title":"Barriers to access to hematopoietic cell transplantation among patients with acute myeloid leukemia in Virginia","volume":"27","author":"Mock","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"2","key":"10.1016\/j.blre.2026.101417_bb0220","first-page":"368","article-title":"Utilization of allogeneic hematopoietic stem cell transplantation among patients with newly diagnosed acute myeloid leukemia in California: a population-based linked dataset study","volume":"110","author":"Meyer","year":"2025","journal-title":"Haematologica"},{"issue":"13","key":"10.1016\/j.blre.2026.101417_bb0225","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1182\/bloodadvances.2023012469","article-title":"Trends in volumes and survival after hematopoietic cell transplantation in racial\/ethnic minorities","volume":"8","author":"Khera","year":"2024","journal-title":"Blood Adv"},{"issue":"23","key":"10.1016\/j.blre.2026.101417_bb0230","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1002\/cncr.33171","article-title":"Age no bar: a CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma","volume":"126","author":"Munshi","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2026.101417_bb0240","author":"Optum"},{"key":"10.1016\/j.blre.2026.101417_bb0245","author":"Merative"},{"key":"10.1016\/j.blre.2026.101417_bb0250","author":"Inovalon"},{"key":"10.1016\/j.blre.2026.101417_bb0255","author":"IQVIA"},{"issue":"7","key":"10.1016\/j.blre.2026.101417_bb0260","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jtct.2022.04.008","article-title":"Socioeconomic and racial disparity in chimeric antigen receptor T cell therapy access","volume":"28","author":"Ahmed","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"9","key":"10.1016\/j.blre.2026.101417_bb0265","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1634\/theoncologist.2018-0019","article-title":"Cost of disease progression in patients with chronic lymphocytic leukemia, acute myeloid leukemia, and non-Hodgkin\u2019s lymphoma","volume":"24","author":"Reyes","year":"2019","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.blre.2026.101417_bb0270","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.clinthera.2022.02.004","article-title":"Burden of illness and treatment patterns in second-line large B-cell lymphoma","volume":"44","author":"Snider","year":"2022","journal-title":"Clin Ther"},{"issue":"6","key":"10.1016\/j.blre.2026.101417_bb0275","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.bbmt.2017.02.017","article-title":"Healthcare costs and utilization for patients age 50 to 64 years with acute myeloid leukemia treated with chemotherapy or with chemotherapy and allogeneic hematopoietic cell transplantation","volume":"23","author":"Preussler","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.blre.2026.101417_bb0285","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.bbmt.2015.04.017","article-title":"Population-based analysis of hematologic malignancy referrals to a Comprehensive Cancer Center, referrals for blood and marrow transplantation, and participation in clinical trial, survey, and biospecimen research by race","volume":"21","author":"Clay","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.blre.2026.101417_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174760","article-title":"Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients","volume":"12","author":"Jabo","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.blre.2026.101417_bb0295","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2710-6","article-title":"Connect MDS\/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study","volume":"16","author":"Steensma","year":"2016","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.blre.2026.101417_bb0300","doi-asserted-by":"crossref","first-page":"460.e1","DOI":"10.1016\/j.jtct.2023.04.011","article-title":"Transplantation referral patterns for patients with newly diagnosed higher-risk myelodysplastic syndromes and acute myeloid leukemia at academic and community sites in the connect\u00ae myeloid disease registry: potential barriers to care","volume":"29","author":"Tomlinson","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.blre.2026.101417_bb0305","author":"Kaiser-Permanente"},{"issue":"5","key":"10.1016\/j.blre.2026.101417_bb0310","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/10428194.2021.2012660","article-title":"Treatment patterns for relapsed and refractory Hodgkin lymphoma in a community oncology setting","volume":"63","author":"Kumar","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.blre.2026.101417_bb0315","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2217\/fon-2020-0522","article-title":"Real-world practice patterns and outcomes in veterans with relapsed\/refractory diffuse large B-cell lymphoma","volume":"17","author":"Chien","year":"2021","journal-title":"Future Oncol"},{"key":"10.1016\/j.blre.2026.101417_bb0320","author":"Administration"},{"issue":"6","key":"10.1016\/j.blre.2026.101417_bb0325","doi-asserted-by":"crossref","first-page":"346.e1","DOI":"10.1016\/j.jtct.2023.03.007","article-title":"Real-world data showing trends and outcomes by race and ethnicity in allogeneic hematopoietic cell transplantation: a report from the Center for International Blood and Marrow Transplant Research","volume":"29","author":"Auletta","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"27","key":"10.1016\/j.blre.2026.101417_bb0330","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1200\/JCO.23.01149","article-title":"Association between state Medicaid policies and accrual of black or Hispanic patients to Cancer clinical trials","volume":"42","author":"Schpero","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2026.101417_bb0335","article-title":"CAR-T for all? Barriers, facilitators, and interventions to commercial CAR T-cell therapy access","author":"Kaparis","year":"2025","journal-title":"Blood Rev"},{"issue":"10","key":"10.1016\/j.blre.2026.101417_bb0340","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.bbmt.2016.05.005","article-title":"Administrative claims data for economic analyses in hematopoietic cell transplantation: challenges and opportunities","volume":"22","author":"Preussler","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.blre.2026.101417_bb0345","doi-asserted-by":"crossref","first-page":"859.e1","DOI":"10.1016\/j.jtct.2022.09.016","article-title":"Linking the Center for International Blood and Marrow Transplant Research Registry to the California Cancer registry and California hospital patient discharge data","volume":"28","author":"THM","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.blre.2026.101417_bb0350","article-title":"Enhancing administrative claims data: feasibility, validation and application of linking Medicare claims data and National Marrow Donor Program Search Data","volume":"6","author":"Preussler","year":"2022","journal-title":"JCO Clin Cancer Inform"},{"issue":"3","key":"10.1016\/j.blre.2026.101417_bb0355","doi-asserted-by":"crossref","first-page":"S414","DOI":"10.1016\/j.bbmt.2016.12.502","article-title":"Lessons learned from merging CIBMTR data and CMS Medicare claims data","volume":"23","author":"Meyer","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"65","key":"10.1016\/j.blre.2026.101417_bb0360","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jncimonographs\/lgae005","article-title":"Virtual pooled registry-Cancer linkage system: an improved method for ascertaining cancer diagnoses","volume":"2024","author":"Deapen","year":"2024","journal-title":"JNCI Monographs"},{"issue":"11","key":"10.1016\/j.blre.2026.101417_bb0370","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/jamia\/ocaa144","article-title":"Recommendations for improving national clinical datasets for health equity research","volume":"27","author":"Block","year":"2020","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.blre.2026.101417_bb0375","doi-asserted-by":"crossref","DOI":"10.2196\/65984","article-title":"Large language model applications for health information extraction in oncology: scoping review","volume":"11","author":"Chen","year":"2025","journal-title":"JMIR Cancer"},{"key":"10.1016\/j.blre.2026.101417_bb0380","doi-asserted-by":"crossref","DOI":"10.2196\/64544","article-title":"Using large language models to automate data extraction from surgical pathology reports: retrospective cohort study","volume":"9","author":"Lee","year":"2025","journal-title":"JMIR Form Res"},{"issue":"1","key":"10.1016\/j.blre.2026.101417_bb0385","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s11689-025-09612-w","article-title":"Automated extraction of functional biomarkers of verbal and ambulatory ability from multi-institutional clinical notes using large language models","volume":"17","author":"Kaster","year":"2025","journal-title":"J Neurodev Disord"},{"key":"10.1016\/j.blre.2026.101417_bb0390","first-page":"574","article-title":"Observational health data sciences and informatics (OHDSI): opportunities for observational researchers","volume":"216","author":"Hripcsak","year":"2015","journal-title":"Stud Health Technol Inform"},{"key":"10.1016\/j.blre.2026.101417_bb0395","first-page":"95","article-title":"The usage of OHDSI OMOP - a scoping review","volume":"283","author":"Reinecke","year":"2021","journal-title":"Stud Health Technol Inform"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X26000561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X26000561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:06:43Z","timestamp":1787951203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X26000561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":73,"alternative-id":["S0268960X26000561"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2026.101417","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What population-based databases reveal about equity in access to hematopoietic cell transplant and cellular therapy","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2026.101417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101417"}}